Our work in drug-resistant TB
The Union advocates for increased research and development, and conducts clinical trials to reduce treatment time and improve outcomes for patients in countries with the highest burdens of disease.
The Union also provides practical and experience-based support to countries implementing care for people with DR-TB. Our expertise is based on our extensive research with partners supporting the nine-month regimen, including partnering on the first randomised control trial into a new regimen for multidrug-resistant TB (TREAT TB).
With the new World Health Organization guidelines focusing on shorter, all oral, regimens for MDR-TB, The Union continues to support countries to implement the latest evidence-based treatments.
TREAT TB
Read more about TREAT TB (Technology, Research, Education and Technical Assistance for Tuberculosis), an ambitious initiative that was launched by The Union, seeking to contribute new knowledge regarding shorter, more tolerable treatment regimens for MDR-TB.
OTHER AREAS OF OUR WORK IN TUBERCULOSIS
You might also be interested in our work on child and adolescent TB and TB-HIV, TB-diabetes and co-morbidities.
The Union used an operational research approach to test a shortened treatment regimen for multidrug-resistant TB. The study first demonstrated a greater than 80% success rate in Bangladesh, Cameroon and Niger and The Union continued to work to develop and implement shorter more effective regimens for the treatment of MDR-TB.
Learn more
Understand the issues with our fact sheets
DR-TB Union news
Nicotine’s new frontier: Why we can’t let big tobacco set the agenda
When the modern e-cigarette first appeared in Shenzhen two decades ago, its inventor, Hon Lik, imagined a cleaner route out of…
Fiscal Policy could be the key to progress in tobacco control – but policy inertia threatens this
Once again, we find ourselves at a turning point in tobacco control. The continued resurgence of the tobacco industry alongside a…
Luther Terry Award 2025 winners reflect on progress and challenges in tobacco control
As we mark World No Tobacco Day, recipients of the 2025 Luther L. Terry Awards reflect on the progress made since the World Conference…
Important step forward in UK tobacco control
As global health leaders, hosts of the World Conference on Tobacco Control 2025 and authors of the Dublin Declaration, The Union…
Tobacco control treaty compromised by global disruptions
According to a new report endorsed by 57 civil society organizations worldwide, the implementation of the WHO Framework Convention on…